文献速递类风湿关节炎其他结缔组织病

纤维肌痛与广泛性疼痛的全因及病因别死亡率:35,248例风湿病患者的观察性研究

All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and clinical fibromyalgia.
PubMed 文献 · Semin Arthritis Rheum · 2020-02-16

在35,248例风湿病患者(含类风湿关节炎26,458例、非炎性风湿病5,167例、临床诊断纤维肌痛3,659例)中随访至多16年,发现各纤维肌痛与广泛性疼痛定义均与全因死亡率呈弱正相关,校正协变量后2016修订标准相对风险降至1.15(95%CI 1.09-1.22);临床诊断纤维肌痛与符合标准定义的纤维肌痛死亡率结局不同,未发现纤维肌痛与癌症死亡的正相关。

要点

  • 各纤维肌痛与广泛性疼痛定义均与全因死亡率弱正相关,校正后2016标准RR为1.15(1.09-1.22)。
  • 类风湿关节炎、非炎性风湿病与临床纤维肌痛中死亡率关联程度相近。
  • 纤维肌痛2016标准相关死亡包括事故、糖尿病、自杀及高血压相关疾病,癌症死亡较少。

核心结论

  • 纤维肌痛与广泛性疼痛在各标准定义下均与死亡率呈弱关联,仅解释3.4%的方差,且在类风湿关节炎、非炎性风湿病与临床纤维肌痛中关联程度相当。
  • 临床诊断纤维肌痛与符合标准定义的纤维肌痛具有不同的死亡率结局,未发现纤维肌痛与癌症死亡的正相关证据。

研究设计与样本

  • 观察性研究,采用Cox回归分析35,248例风湿病患者,随访至多16年。
  • 亚组包括类风湿关节炎26,458例、非炎性风湿病5,167例、临床诊断纤维肌痛3,659例。
  • 应用2016年纤维肌痛标准及其他纤维肌痛与广泛性疼痛标准,建立年龄性别校正模型与全协变量模型,并以解释方差(R2)衡量预测能力。

主要发现

  • 年龄性别校正下,ACR 1990广泛性疼痛全因死亡RR为1.19(95%CI 1.15-1.24),2016修订标准为1.38(1.31-1.46)。
  • 全协变量模型中2016标准RR降至1.15(1.09-1.22)。
  • 各疾病亚组死亡关联:类风湿关节炎1.52(1.43-1.61)、非炎性风湿病1.43(1.24-1.66)、临床纤维肌痛1.41(1.14-1.75),其中37%临床诊断纤维肌痛患者不满足2016标准。
  • 全患者分析中年龄性别解释方差R2为0.255,加入2016标准后升至0.264(4.4%),全协变量模型为0.378。

关键数值与推荐

  • 2016年纤维肌痛标准年龄性别校正全因死亡RR为1.38(95%CI 1.31-1.46),全协变量模型为1.15(1.09-1.22)。
  • ACR 1990广泛性疼痛标准年龄性别校正全因死亡RR为1.19(95%CI 1.15-1.24)。
  • 纤维肌痛2016标准仅解释3.4%的死亡方差。

临床怎么用

  • 对纤维肌痛患者应关注事故、糖尿病、自杀及高血压相关疾病等特定死亡原因。
  • 临床诊断纤维肌痛与符合标准定义的纤维肌痛死亡率结局不同,评估时需注意诊断方式差异。
  • 纤维肌痛与癌症死亡无正相关,不必据此过度筛查癌症。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Studies of the relation of fibromyalgia (FM) and widespread pain (WSP) to mortality have differed as to the presence or absence of an association and the extent of cause-specific mortality. However, no studies have investigated which definitions of FM and WSP associate with mortality, nor of FM mortality in other diseases. We investigated these issues and the meaning of mortality in patients with FM. METHODS: We used Cox regression to study 35,248 rheumatic disease patients with up to 16 years of mortality follow-up in all patients and separately in those with diagnoses of rheumatoid arthritis (RA) (N = 26,458), non-inflammatory rheumatic disorders (NIRMD) (N = 5,167) and clinically diagnosed FM (N = 3,659). We applied 2016 FM criteria and other FM and WSP criteria to models adjusted for age and sex as well as to models that included a full range of covariates, including comorbid disease and functional status. We estimated the degree of explained of variance (R2) as a measure of predictive ability. RESULTS: We found positive associations between al`l definitions of FM and WSP and all-cause mortality, with relative risks (RR)s ranging from 1.19 (95%CI 1.15-1.24) for American College of Rheumatology (ACR) 1990 WSP to 1.38 (1.31-1.46) in age and sex adjusted revised 2016 criteria (FM 2016). However, in full covariate models the FM 2016 RR reduced further to 1.15 (1.09-1.22). The association with mortality was noted with RA (1.52 (1.43-1.61)), NIRMD (1.43 (1.24-1.66)) and clinical FM (1.41 (1.14-1.75) - where 37% of FM diagnosed patients did not satisfy FM 2016 criteria. In the all-patient analyses, the age and sex explained variation (R2) was 0.255, increasing to 0.264 (4.4%) when FM 2016 criteria were added, and to 0.378 in a full covariate model. Death causes related to FM 2016 status included accidents, 1.45 (1.11-1.91); diabetes 1.78 (1.16-2,71); suicide, 3.01 (1.55-5.84) and hypertensive related disorders, 3.01 (1.55-5.84). Cancer deaths were less common 0.77 (0.68-0.88). CONCLUSIONS: FM is weakly associated with mortality within all criteria definitions of FM and WSP examined (3.4% of explained variance), and across all diseases (RA, NIRMD, clinical FM) equally. Clinical and criteria-defined FM had different mortality outcomes. We found no evidence for a positive association of cancer and FM or WSP.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Wolfe F, Ablin J, Baker JF, et al. All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and clinical fibromyalgia. Semin Arthritis Rheum. 2020. PMID: 32173059. doi:10.1016/j.semarthrit.2020.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。